Clinical Trial Update: Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Metabolic Dysfunction Associated Steatotic Liver Disease | Phase 2 | Status: RECRUITING